News . Data . Research
Akebia Therapeutics Inc (AKBA) Q1 2020 earnings call dated May 05, 2020 Corporate Participants: Kristen Sheppard -- Vice President, Investor Relations John Butler -- President and
This year, we saw long red candles replacing clowns as the ultimate symbol of horror. It has given sleepless nights to not
Incyte Corp (INCY) Q1 2020 earnings call dated May 05, 2020 Corporate Participants: Michael Booth -- Division Vice President-Investor Relations & Corporate Responsibility Herve
Moderna Inc (MRNA) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane Bancel -- Chief Executive Officer
Corcept Therapeutics Incorporated (CORT) Q1 2020 earnings call dated May 04, 2020 Corporate Participants: Charles Robb -- Chief Financial Officer Joseph K Belanoff -- Chief Executive
Moderna Inc (MRNA) Q1 2019 interim phase 1 data conference call dated May. 18, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations
Novo Nordisk A/S (NVO) Q1 2020 earnings call dated May. 06, 2020 Corporate Participants: Lars Fruergaard Jorgensen -- President and Chief Executive Officer Mads
The entire world is waiting for some good news on a vaccine for the novel coronavirus. So far the global pandemic has
Aurinia Pharmaceuticals Inc. (AUPH) Q1 2020 earnings call dated May. 14, 2020 Corporate Participants: Glenn Schulman -- Head of Investor Relations and Corporate Communications
When most of the companies were discussing how they got impacted by the deadly virus and the uncertainties they faced in the
Veru Inc (NASDAQ: VERU) is the latest company to jump into the bandwagon of firms around the world vying for a drug
Catalyst Pharmaceuticals Inc (CPRX) Q1 2020 earnings call dated May 12, 2020 Corporate Participants: Alicia Grande -- Vice President, Chief Financial Officer and Treasurer
INOVIO Pharmaceuticals (NASDAQ: INO), which is among the frontrunners in developing a vaccine for the coronavirus disease, said during its post-earnings conference
Inovio Pharmaceuticals Inc (INO) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Ben Matone -- Investor Relations J. Joseph Kim, Ph.D. -- President, Chief
Palatin Technologies, Inc. (NYSE: PTN) reported a narrower loss in the third quarter of fiscal 2020 helped by lower operating expenses as
Cara Therapeutics Inc. (CARA) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Jack Hildick-Smith -- Investor Relations Derek Chalmers -- Chief Executive Officer, President,
Intercept Pharmaceuticals Inc (ICPT) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Lisa DeFrancesco -- Vice President, Investor Relations Mark Pruzanski -- President, Chief
Alnylam Pharmaceuticals Inc (ALNY) Q1 2020 earnings call dated May. 06, 2020 Corporate Participants: Christine Regan Lindenboom -- Vice President, Investor Relations and Corporate
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported a 36% jump in earnings for the first quarter of 2020 helped by higher revenue. The
COVID-19 has been pretty disruptive on clinical-level biotech and pharmaceutical companies worldwide, especially those running on tight budgets. Clinical trials have been
Viking Therapeutics Inc (VKTX) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Stephanie Diaz -- Manager, Investor Relations Brian Lian -- President and Chief